{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T13:09:37Z","timestamp":1788786577732,"version":"build-2803163510"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","gynecologiconcology-online.net","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.ygyno.2024.02.028","type":"journal-article","created":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T16:19:20Z","timestamp":1709914760000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Integration and usability of a digital cancer risk stratification tool to optimize identification of patients at risk for hereditary cancers: A pilot study"],"prefix":"10.1016","volume":"183","author":[{"given":"Emily M.","family":"Webster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiza","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Danyal","family":"Ahsan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Levi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Chandler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlene","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kemi","family":"Babagbemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi N.","family":"Sharaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa K.","family":"Frey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"24","key":"10.1016\/j.ygyno.2024.02.028_bb0005","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1056\/NEJMoa1508054","article-title":"Germline mutations in predisposition genes in pediatric Cancer","volume":"373","author":"Zhang","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"15","key":"10.1016\/j.ygyno.2024.02.028_bb0010","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1158\/1078-0432.CCR-15-1465","article-title":"Effectiveness of prophylactic surgeries in BRCA1 or BRCA2 mutation carriers: a Meta-analysis and systematic review","volume":"22","author":"Li","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.ygyno.2024.02.028_bb0015","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1053\/j.gastro.2005.11.032","article-title":"Decrease in mortality in lynch syndrome families because of surveillance","volume":"130","author":"de Jong","year":"2006","journal-title":"Gastroenterology."},{"key":"10.1016\/j.ygyno.2024.02.028_bb0020","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13053-016-0048-3","article-title":"Intensive breast screening in BRCA2 mutation carriers is associated with reduced breast cancer specific and all cause mortality","volume":"14","author":"Evans","year":"2016","journal-title":"Hered Cancer Clin. Pract."},{"issue":"4","key":"10.1016\/j.ygyno.2024.02.028_bb0025","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.amjsurg.2016.06.010","article-title":"Risk reduction and survival benefit of prophylactic surgery in BRCA mutation carriers, a systematic review","volume":"212","author":"Ludwig","year":"2016","journal-title":"Am. J. Surg."},{"issue":"2","key":"10.1016\/j.ygyno.2024.02.028_bb0030","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.cgh.2009.10.003","article-title":"Efficacy of annual colonoscopic surveillance in individuals with hereditary nonpolyposis colorectal cancer","volume":"8","author":"Engel","year":"2010","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"18","key":"10.1016\/j.ygyno.2024.02.028_bb0035","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1001\/jama.286.18.2251","article-title":"Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and bowel project (NSABP-P1) breast Cancer prevention trial","volume":"286","author":"King","year":"2001","journal-title":"JAMA."},{"issue":"2","key":"10.1016\/j.ygyno.2024.02.028_bb0040","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/ajg.2014.435","article-title":"ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes","volume":"110","author":"Syngal","year":"2015","journal-title":"Am. J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.ygyno.2024.02.028_bb0045","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/gim.2014.147","article-title":"A practice guideline from the American College of Medical Genetics and Genomics and the National Society of genetic counselors: referral indications for cancer predisposition assessment","volume":"17","author":"Hampel","year":"2015","journal-title":"Genet. Med."},{"issue":"6","key":"10.1016\/j.ygyno.2024.02.028_bb0050","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1097\/AOG.0000000000003562","article-title":"ACOG COMMITTEE OPINION, Number 793","volume":"134","author":"Hereditary Cancer Syndromes and Risk Assessment","year":"2019","journal-title":"Obstet. Gynecol."},{"issue":"5","key":"10.1016\/j.ygyno.2024.02.028_bb0055","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1097\/01.AOG.0000456325.50739.72","article-title":"147: lynch syndrome","volume":"124","author":"ACOG Practice Bulletin No","year":"2014","journal-title":"Obstet. Gynecol."},{"issue":"10","key":"10.1016\/j.ygyno.2024.02.028_bb0060","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1245\/s10434-019-07549-8","article-title":"Consensus guidelines on genetic; testing for hereditary breast Cancer from the American Society of Breast Surgeons","volume":"26","author":"Manahan","year":"2019","journal-title":"Ann. Surg. Oncol."},{"issue":"11","key":"10.1016\/j.ygyno.2024.02.028_bb0065","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1200\/JCO.19.02960","article-title":"Germline and somatic tumor testing in epithelial ovarian cancer: ASCO guideline","volume":"38","author":"Konstantinopoulos","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2024.02.028_bb0070","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1200\/JCO.18.01489","article-title":"Evaluating susceptibility to pancreatic Cancer: ASCO provisional clinical Opinion","volume":"37","author":"Stoffel","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2024.02.028_bb0075","author":"National Health Service"},{"issue":"24","key":"10.1016\/j.ygyno.2024.02.028_bb0080","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1200\/JCO.20.00046","article-title":"Implementation of germline testing for prostate Cancer: Philadelphia prostate Cancer consensus conference 2019","volume":"38","author":"Giri","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2024.02.028_bb0085","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ygyno.2014.09.009","article-title":"Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions","volume":"136","author":"Lancaster","year":"2015","journal-title":"Gynecol. Oncol."},{"issue":"7","key":"10.1016\/j.ygyno.2024.02.028_bb0090","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1001\/jama.2019.8430","article-title":"Risk assessment, genetic counseling, and genetic testing for BRCA-related Cancer in women: updated evidence report and systematic review for the US preventive services task force","volume":"322","author":"Nelson","year":"2019","journal-title":"JAMA."},{"key":"10.1016\/j.ygyno.2024.02.028_bb0095","author":"Centers for Disease Control and Prevention"},{"key":"10.1016\/j.ygyno.2024.02.028_bb0100","series-title":"Breast Cancer Risk Reduction (Version 1.2023). NCCN Clinical Practice Guidelines in Oncology","author":"National Comprehensive Cancer Network","year":"2023"},{"key":"10.1016\/j.ygyno.2024.02.028_bb0105","series-title":"Breast Cancer Screening and Diagnosis (Version 1.2022)","author":"National Comprehensive Cancer Network","year":"2022"},{"issue":"1","key":"10.1016\/j.ygyno.2024.02.028_bb0110","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1086\/301670","article-title":"Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2","volume":"62","author":"Parmigiani","year":"1998","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ygyno.2024.02.028_bb0115","author":"Ikonopedia"},{"key":"10.1016\/j.ygyno.2024.02.028_bb0120","author":"National Cancer Institute"},{"issue":"6","key":"10.1016\/j.ygyno.2024.02.028_bb0125","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1245\/s10434-012-2257-y","article-title":"Hereditary breast and ovarian cancer and other hereditary syndromes: using technology to identify carriers","volume":"19","author":"Drohan","year":"2012","journal-title":"Ann. Surg. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2024.02.028_bb0130","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1089\/gtmb.2009.0037","article-title":"Cancer genetic risk assessment and referral patterns in primary care","volume":"13","author":"Vig","year":"2009","journal-title":"Genet. Test. Mol. Biomark."},{"issue":"22","key":"10.1016\/j.ygyno.2024.02.028_bb0135","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1056\/NEJMsb042979","article-title":"The family history--more important than ever","volume":"351","author":"Guttmacher","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2024.02.028_bb0140","article-title":"Room for improvement in capturing cancer family history in a gynecologic oncology outpatient setting","volume":"40","author":"Lin","year":"2022","journal-title":"Gynecol. Oncol. Rep."},{"issue":"6","key":"10.1016\/j.ygyno.2024.02.028_bb0145","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/ejhg.2014.180","article-title":"A systematic review of factors that act as barriers to patient referral to genetic services","volume":"23","author":"Delikurt","year":"2015","journal-title":"Eur. J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.ygyno.2024.02.028_bb0150","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ygyno.2021.05.011","article-title":"Achieving universal genetic assessment for women with ovarian cancer: are we there yet? A systematic review and meta-analysis","volume":"162","author":"Lin","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2024.02.028_bb0155","article-title":"Chatbot artificial intelligence for genetic Cancer risk assessment and counseling: a systematic review and Meta-analysis","volume":"7","author":"Webster","year":"2023","journal-title":"JCO Clin. Cancer Inform."},{"issue":"Suppl. 1","key":"10.1016\/j.ygyno.2024.02.028_bb0160","doi-asserted-by":"crossref","first-page":"S239","DOI":"10.1016\/j.acra.2020.12.005","article-title":"A breast radiology department-operated, proactive same-day program identifies pathogenic breast Cancer mutations in unaffected women","volume":"29","author":"Loving","year":"2022","journal-title":"Acad. Radiol."},{"issue":"6","key":"10.1016\/j.ygyno.2024.02.028_bb0165","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/AOG.0000000000004596","article-title":"Hereditary Cancer risk using a genetic Chatbot before routine care visits","volume":"138","author":"Nazareth","year":"2021","journal-title":"Obstet. Gynecol."},{"issue":"5","key":"10.1016\/j.ygyno.2024.02.028_bb0170","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.pec.2021.02.034","article-title":"Utility of a virtual counselor (VICKY) to collect family health histories among vulnerable patient populations: a randomized controlled trial","volume":"104","author":"Wang","year":"2021","journal-title":"Patient Educ. Couns."},{"key":"10.1016\/j.ygyno.2024.02.028_bb0175","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1200\/CCI.21.00004","article-title":"Leveraging health information technology to collect family Cancer history: a systematic review and Meta-analysis","volume":"5","author":"Li","year":"2021","journal-title":"JCO Clin. Cancer Inform."},{"key":"10.1016\/j.ygyno.2024.02.028_bb0180","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ygyno.2023.04.001","article-title":"Web-based tool for cancer family history collection: a prospective randomized controlled trial","volume":"173","author":"Frey","year":"2023","journal-title":"Gynecol. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2024.02.028_bb0185","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/jgc4.1239","article-title":"Family health history collected by virtual conversational agents: an empirical study to investigate the efficacy of this approach","volume":"29","author":"Ponathil","year":"2020","journal-title":"J. Genet. Couns."},{"key":"10.1016\/j.ygyno.2024.02.028_bb0190","author":"Ambry Genetics"},{"key":"10.1016\/j.ygyno.2024.02.028_bb0195","series-title":"Genetic\/Familial High-Risk Assessment: Colorectal (Version 1.2022)","author":"National Comprehensive Cancer Network","year":"2022"},{"key":"10.1016\/j.ygyno.2024.02.028_bb0200","series-title":"Genetic\/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic (Version 3.2023)","author":"National Comprehensive Cancer Network","year":"2023"},{"key":"10.1016\/j.ygyno.2024.02.028_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2024.01.009","article-title":"Implementation of a smartphone survey and mainstreaming for genetic cancer risk assessment in a diverse, urban, Medicaid-predominant gynecology clinic: a step toward health equity","author":"Webster","year":"2024","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"7","key":"10.1016\/j.ygyno.2024.02.028_bb0210","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1080\/10447318.2018.1455307","article-title":"The system usability scale: past, present, and future","volume":"34","author":"Lewis","year":"2018","journal-title":"Int. J. Human\u2013Comput. Inter."},{"issue":"5","key":"10.1016\/j.ygyno.2024.02.028_bb0215","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.intcom.2010.04.004","article-title":"The usability metric for user experience","volume":"22","author":"Finstad","year":"2010","journal-title":"Interact. Comput."},{"key":"10.1016\/j.ygyno.2024.02.028_bb0220","first-page":"189","article-title":"SUS: a quick and dirty usability scale","author":"Brooke","year":"1995","journal-title":"Usability Eval. Ind."},{"issue":"Suppl. 3","key":"10.1016\/j.ygyno.2024.02.028_bb0225","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/10810730.2012.712615","article-title":"Measurement variation across health literacy assessments: implications for assessment selection in research and practice","volume":"17","author":"Haun","year":"2012","journal-title":"J. Health Commun."},{"issue":"3","key":"10.1016\/j.ygyno.2024.02.028_bb0230","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3122\/jabfm.2015.03.140149","article-title":"Prompting primary care providers about increased patient risk as a result of family history: does it work?","volume":"28","author":"Zazove","year":"2015","journal-title":"J. Am. Board Fam. Med."},{"issue":"1","key":"10.1016\/j.ygyno.2024.02.028_bb0235","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11606-020-06064-x","article-title":"Racial and ethnic disparities in genetic testing at a hereditary breast and ovarian Cancer center","volume":"36","author":"Chapman-Davis","year":"2021","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.ygyno.2024.02.028_bb0240","first-page":"1","article-title":"Genetic testing for all: overcoming disparities in ovarian Cancer genetic testing","volume":"42","author":"Frey","year":"2022","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"issue":"3","key":"10.1016\/j.ygyno.2024.02.028_bb0245","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s12609-020-00364-1","article-title":"Disparities in genetic testing and care among black women with hereditary breast Cancer","volume":"12","author":"Reid","year":"2020","journal-title":"Curr. Breast Cancer Rep."},{"issue":"13","key":"10.1016\/j.ygyno.2024.02.028_bb0250","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1002\/cncr.30621","article-title":"Racial disparities in BRCA testing and cancer risk management across a population-based sample of young breast cancer survivors","volume":"123","author":"Cragun","year":"2017","journal-title":"Cancer."},{"issue":"14","key":"10.1016\/j.ygyno.2024.02.028_bb0255","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/jama.293.14.1729","article-title":"Racial differences in the use of BRCA1\/2 testing among women with a family history of breast or ovarian cancer","volume":"293","author":"Armstrong","year":"2005","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ygyno.2024.02.028_bb0260","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ygyno.2019.01.024","article-title":"Disparities in gynecologic cancer genetics evaluation","volume":"153","author":"Hinchcliff","year":"2019","journal-title":"Gynecol. Oncol."},{"issue":"10","key":"10.1016\/j.ygyno.2024.02.028_bb0265","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1093\/oncolo\/oyac132","article-title":"The role of race and insurance status in access to genetic counseling and testing among high-risk breast Cancer patients","volume":"27","author":"Choi","year":"2022","journal-title":"Oncologist."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825824001380?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825824001380?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T11:06:36Z","timestamp":1717499196000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825824001380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":53,"alternative-id":["S0090825824001380"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2024.02.028","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integration and usability of a digital cancer risk stratification tool to optimize identification of patients at risk for hereditary cancers: A pilot study","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2024.02.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}